Search Results for "Today"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Today. Results 11 to 20 of 21 total matches.
Corneal Surgery for Correction of Refractive Errors
The Medical Letter on Drugs and Therapeutics • Dec 17, 1999 (Issue 1068)
Waring et al, Arch Ophthalmol, 112:1298,
1994). RK is rarely performed today.
INTRACORNEAL RINGS ...
All refractive corneal surgery reshapes the cornea to redirect light rays so that they focus on the retine....
Remimazolam (Byfavo) for Short-Term Procedural Sedation
The Medical Letter on Drugs and Therapeutics • Feb 21, 2022 (Issue 1644)
. Drugs Today (Barc) 2021; 57:337.
2. DK Rex et al. A phase III study evaluating the efficacy and safety ...
The FDA has approved remimazolam (Byfavo – Acacia
Pharma), an ultra-short-acting IV benzodiazepine,
for induction and maintenance of sedation in adults
undergoing procedures of up to 30 minutes' duration.
Prostate Cancer Screening
The Medical Letter on Drugs and Therapeutics • Nov 03, 2008 (Issue 1298)
diagnosed with
prostate cancer in the US today (even with low-grade,
early-stage disease) choose ...
The US Preventive Services Task Force (USPSTF) has recently concluded that available evidence is insufficient to assess the balance between potential benefits and harms of using the prostate-specific antigen (PSA) to screen men < 75 years old for prostate cancer and has recommended against screening men > 75 years old.
Clarithromycin in Patients with Coronary Artery Disease
The Medical Letter on Drugs and Therapeutics • May 21, 2018 (Issue 1547)
prolongation, TdP and sudden
death. Cardiology Today 2017 Sept (epub).
6. DN Juurlink. The cardiovascular ...
The FDA has warned that use of the macrolide
antibiotic clarithromycin (Biaxin, and generics) may
increase the risk of cardiovascular morbidity and
mortality in patients with heart disease.
Zuranolone (Zurzuvae) – An Oral Drug for Postpartum Depression
The Medical Letter on Drugs and Therapeutics • Dec 25, 2023 (Issue 1692)
Today 2019; 24:606.
5. KM Deligiannidis et al. Zuranolone for the treatment of
postpartum depression ...
The FDA has approved the oral GABAA receptor
modulator zuranolone (Zurzuvae – Sage Therapeutics/Biogen) for treatment of postpartum depression
(PPD). Zuranolone is the second drug to be approved
for this indication; brexanolone (Zulresso), another
GABAA receptor modulator, was approved for IV
treatment of PPD in 2019.
Med Lett Drugs Ther. 2023 Dec 25;65(1692):201-3 doi:10.58347/tml.2023.1692a | Show Introduction Hide Introduction
Lasik and Its Alternatives: An Update
The Medical Letter on Drugs and Therapeutics • Jan 19, 2004 (Issue 1174)
account for only a small percentage of refractive surgery procedures today.
PHAKIC INTRAOCULAR LENSES ...
Since the last Medical Letter article on surgical correction of refractive errors (Volume 41, page 122, 1999), some new techniques have been tried and new results have been reported.
Acupuncture
The Medical Letter on Drugs and Therapeutics • May 08, 2006 (Issue 1234)
that acupuncture was used in China as
the only anesthetic in major surgery,
7
acupuncture
today is regarded ...
Acupuncture is the practice of inserting fine needles for therapeutic purposes into points on the skin known as acupoints. In traditional Chinese medicine theory, these points arefound along channels that conduct "qi" (pronounced "chee"), or energy. In addition to insertion of needles, acupoints can be stimulated by heat, electrical current or just pressure.
Phexxi - A Nonhormonal Contraceptive Gel
The Medical Letter on Drugs and Therapeutics • Aug 24, 2020 (Issue 1605)
: difficult to insert, less widely
available
Male: allergic reactions, breakage
possible
Sponge
Today ...
The FDA has approved Phexxi (Evofem), a
nonhormonal prescription-only vaginal gel containing
lactic acid, citric acid, and potassium bitartrate, for
prevention of pregnancy. The gel is intended for on-demand
contraception; it is not effective when used
after intercourse. It was previously approved for
use as a vaginal lubricant (Amphora), but was never
marketed.
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • May 15, 2023 (Issue 1676)
High failure rate; allergic reactions;
poor acceptability; breakage
possible
Sponge
Today 14%/27%7 ...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective in
preventing pregnancy. When used alone, barrier and
behavioral methods generally have higher failure
rates than other methods (see Table 1). Selection of
a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80 doi:10.58347/tml.2023.1676a | Show Introduction Hide Introduction
Drugs for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Feb 22, 2021 (Issue 1618)
disease: a review. JAMA 2020; 323:548.
3. SH Fox and AW Lang. "Don't delay, start today": delaying ...
The motor symptoms of Parkinson's disease (PD) are
caused primarily by degeneration of dopaminergic
neurons in the substantia nigra. The nonmotor symptoms
of the disease are thought to be caused by degeneration of
other neurotransmitter systems. No disease-modifying
drugs are available for treatment of PD.